Cannabis Law Report

JULY 31, 2019

billion by 2025, according to a new report by Grand View Research, Inc., The market is primarily driven by the ongoing legalization of medical marijuana for treating patients with Parkinson’s disease, cancer, arthritis, Alzheimer’s disease, neurologic problems such as depression, anxiety, & epilepsy, and others.

Chronic Pain 40

Chronic Pain Epilepsy Treatment Recreational 40

Cannabis Law Report

JANUARY 12, 2020

It has approved use of cannabis extracts for treatment of a range of illnesses and conditions, including cancer, epilepsy, Alzheimer’s, Parkinson’s disease and anxiety. According to a 2019 study by Grand View Research, a US-based market research firm, the global legal marijuana market is expected to be worth US$66.3

Research and Development 59

Research and Development Marijuana Agriculture Medicine 59

Cannabis Law Report

JULY 26, 2019

The medicinal cannabis is believed to possess traits that cure critical ailments like Cancer, AIDS, cancer, PTSD, depression, epilepsy and seizures. The Australian cannabis market is expected to have a net worth of approximately $55 million by the end of 2025. per cent at A$0.625 on ASX on 25 July 2019.

Banking 45

Banking Medicine Research and Development Recreational 45

Cannabis Law Report

JANUARY 5, 2022

3 MyMD believes that there are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 according to a major investment bank. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Therapy Treatment 52

Cannabis Law Report

SEPTEMBER 13, 2021

Commenting on the size and scope of the market for delaying aging, Dr. Chapman added, “There are no FDA-approved drugs for treating aging disorders and extending healthy lifespan in humans, a market expected to be at least $600 billion by 2025 1 according to a major investment bank. 3 Nature Aging | VOL 1 | July 2021 | p. 646) 421-9523.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 16, 2021

The market for treating aging disorders and extending healthy lifespan is expected to be at least $600 billion by 2025 1 according to a major investment bank. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. For more information, visit www.mymd.com. 616–623.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

FEBRUARY 18, 2020

Researchers predict that the market will be valued at $7 billion by the year 2025. And according to a Nielsen analytical report , the US market of legal marijuana will reach $41 billion in revenue by 2025, meaning that New York will make up close to 17% of the market share. In 2018, the New York legal cannabis market reached $1.8

Marijuana 59

Marijuana Consumption Dispensary Vaping 59